<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Wallentin, Lars</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Beyond the Guidelines: New Evidence in AF</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">31-32</style></pages><abstract><style  face="normal" font="default" size="100%">Despite the increasing prevalence of atrial fibrillation (AF), no reliable method to detect AF in asymptomatic individuals has been established. This diagnostic uncertainty poses a challenge in implementing important treatment decisions, such as rate versus rhythm control and the need for anticoagulation in asymptomatic patients [Eitel C et al. Europace 2011].</style></abstract><number><style face="normal" font="default" size="100%">10</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>